02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

276 HYDROCORTISONE<br />

Reactions<br />

Skin<br />

Acne<br />

Allergic reactions (sic)<br />

(2004): Keegel T+, Contact Dermatitis 50(1), 6<br />

(1999): Kamm GL+, Ann Pharmacother 33(4), 451<br />

(1995): Lepoittevin JP+, Arch Dermatol 131(1), 31<br />

(1992): Schoenmakers A+, Contact Dermatitis 26(3), 159<br />

(1991): Lauerma AI+, JAmAcadDermatol24(2), 182<br />

(1989): Reitamo S+, JAmAcadDermatol21(3), 506<br />

(1986): Dooms-Goossens A+, Contact Dermatitis 14(2), 94<br />

(1980): Brown R, Contact Dermatitis 6(7), 504<br />

Angioedema<br />

(1980): Ashford RF+, Postgrad Med J 56(656), 437<br />

Atrophy<br />

(1985): Serup J+, Dermatologica 170(4), 189<br />

Bruising<br />

Burning<br />

(1997): Sears HW+, Clin Ther 19(4), 710<br />

Dermatitis<br />

(1998): Isaksson M+, Am J Contact Dermat 9(2), 136<br />

(1997): Vestergaard L+, Ugeskr Laeger (Danish) 159, 5662<br />

(1995): Wilkinson SM+, Br J Dermatol 132(5), 766<br />

(1993): Hisa T+, Contact Dermatitis 28, 174<br />

(1993): Torres V+, Contact Dermatitis 29(2), 106<br />

(1992): Wilkinson SM+, Contact Dermatitis 27(3), 197<br />

(1991): Dunkel FG+, Contact Dermatitis 25(2), 97<br />

(1991): Marston S, Contact Dermatitis 24(5), 372<br />

(1985): Yoshikawa K+, Contact Dermatitis 12, 55<br />

Eczema<br />

(1996): Juhlin L, Cutis 57(2), 51 (exacerbation)<br />

(1993): Torres V+, Contact Dermatitis 29, 106<br />

(1992): Lauerma AI+, Arch Dermatol 128, 275<br />

(1991): Wilkinson SM+, Lancet 337(8744), 761 (4.8%)<br />

Molluscum contagiosum<br />

(1990): Ratka P+, Dermatol Monatsschr 176(12), 735<br />

Photoallergic reaction<br />

(1996): Stitt WZ+, Am J Contact Dermat 7(3), 166<br />

Pruritus<br />

(2004): El Mekki+, Presse Med 33(9 Pt 1), 604<br />

Purpura<br />

(2004): El Mekki+, Presse Med 33(9 Pt 1), 604<br />

Rash (sic)<br />

(1999): Vaghjimal A+, Int J Clin Pract 53(7), 567<br />

(1993): Hisa T+, Contact Dermatitis 28(3), 174<br />

Sensitivity<br />

(2000): Bircher AJ+, Dermatology 200(4), 349<br />

Telangiectasia<br />

(1985): Serup J+, Dermatologica 170(4), 189<br />

Urticaria<br />

(2001): Borja JM+, Allergy 56(8), 802<br />

(2001): Nettis E+, Allergy 56(8), 791<br />

(2001): Rasanen L+, Allergy 56, 352<br />

(1987): Kuokkanen K+, Clin Ther 9(2), 223 (1 case)<br />

(1980): Ashford RF+, Postgrad Med J 56(656), 437<br />

Hair<br />

Hair – hypertrichosis<br />

Eyes<br />

Cataract<br />

(1996): Phillips CI+, Acta Derm Venereol 76(4), 314<br />

Visual disturbances<br />

Other<br />

Anaphylactoid reactions/Anaphylaxis<br />

(2004): Calogiuri GF+, Br J Dermatol 151(3), 707<br />

(2002): Holz W+, Anaesthesist 51(3), 187<br />

(1993): Yoshikawa T+, Nihon Kyobu Shikkan Gakkai Zasshi<br />

31(8), 1024<br />

(1992): Corominas N+, Pharm Weekbl Sci 14(3), 93<br />

(1991): Fulcher DA+, Med J Aust 154(3), 210<br />

(1991): Kawane H, Med J Aust 154(11), 783<br />

(1991): Murrieta-Aguttes M+, JAsthma28(5), 329<br />

(1990): Suenaga N+, Nihon Kyobu Shikkan Gakkai Zasshi<br />

28(6), 900<br />

(1986): Mansfield LE+, J Asthma 23(2), 81<br />

(1985): Goldstein DA+, Ann Allergy 55(4), 599<br />

(1985): Murata Y+, Nihon Kyobu Shikkan Gakkai Zasshi<br />

23(3), 375<br />

(1985): Peller JS+, Ann Allergy 54, 302<br />

(1984): Chan CS+, Med J Aust 141(7), 444<br />

(1984): Rogov VD, Vestn Otorinolaringol 647(4), 66<br />

(1982): Tada T+, Kokyu To Junkan 30(11), 1173<br />

(1981): Dajani BM+, J Allergy Clin 68, 201<br />

Fever<br />

(1999): Vaghjimal A+, Int J Clin Pract 53(7), 567<br />

Hypersensitivity<br />

(2002): Le Coz, Ann Dermatol Venereol 129(6-7), 931<br />

(1994): Wilkinson SM+, Br J Dermatol 131(4), 495<br />

(1993): Lauerma AI+, Contact Dermatitis 28(1), 10<br />

(1993): Wilkinson SM+, Contact Dermatitis 28(5), 295<br />

(1992): Burden AD+, Br J Dermatol 127(5), 497 (2.5%)<br />

Infections<br />

(2003): Lionakis MS+, Lancet 362(9398), 1828<br />

Myalgia/Myositis/Myopathy/Myotoxicity<br />

(2004): Tsai WS+, Am J Med Sci 327(3), 152<br />

(1990): Shee CD, Respir Med 84(3), 229<br />

(1990): Shee CD, Respiratory Medicine 84, 229<br />

(1988): Sury MR+, Lancet 2(8609), 515<br />

(1986): Knox AJ+, Thorax 41, 411<br />

(1986): Knox AJ+, Thorax 41(5), 411<br />

(1980): Van Marle W+, BMJ 281, 271<br />

(1980): Van Marle W+, Br Med J 281(6235), 271<br />

HYDROFLUMETHIAZIDE*<br />

Trade names: Diademil; Hydravern; Hydrenox; Leodrine;<br />

Rivosil; Rontyl<br />

Indications: Hypertension, edema<br />

Category: Diuretic, thiazide<br />

Half-life: 12–24 hours<br />

Clinically important, potentially hazardous interactions<br />

with: digoxin, lithium<br />

Reactions<br />

Skin<br />

Photosensitivity (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!